Decision on funding abortion pill months away

The Canadian Drug Expert Committee has recommended abortion pill Mifegymiso be covered by public drug plans, but a decision about whether the Manitoba government will fund it is months away.

The committee released its decision this week, citing two reasons: the drug has a success rate of between 95 and 97 per cent, and adverse reactions experienced by patients are in line with those one would expect from expelling a fetus (nausea, vomiting, diarrhea).

Read the full article...